West Pharmaceutical Servs Raises FY2026 GAAP EPS Guidance from $7.79-$8.14 to $8.15-$8.50 vs $7.91 Est
Benzinga Newsdesk 6 months ago
NewsGuidance
West Pharmaceutical Servs (NYSE:WST) raises FY2026 GAAP EPS guidance from $7.79-$8.14 to $8.15-$8.50 vs $7.91 analyst estimate..
West Pharmaceutical Servs (NYSE:WST) raises FY2026 GAAP EPS guidance from $7.79-$8.14 to $8.15-$8.50 vs $7.91 analyst estimate..